코미팜은 식약처가 허가할 경우 코로나19 폐렴 진단자 100명을 대상으로 임상시험을 실시할 것이라고 밝혔다.
Komipharm said that it will conduct a clinical trial on 100 patients diagnosed with COVID-19 pneumonia if approved by the Ministry of Food and Drug Safety.